EQS-News: Abivax announces presentation of four abstracts for obefazimod in ulcerative colitis and sponsorship of scientific symposium at the 19th Congress of European Crohn’s and Colitis Organization (ECCO)
“We are delighted that all four submitted abstracts have been accepted for presentations at ECCO.
- “We are delighted that all four submitted abstracts have been accepted for presentations at ECCO.
- We look forward to scientific exchange with the IBD community at ECCO,” said Sheldon Sloan, M.D., M. Bioethics, Chief Medical Officer of Abivax.
- (Germany), on February 23, 2024, at 7:15-8:15 a.m. CET in room A12.
- The Symposium will be broadcasted live and is accessible publicly here .